Dental infection is risk for preterm birth (PTB) through unclear mechanisms. We established a dental infection-induced PTB mouse model, in which Porphyromonas gingivalis (P.g.) induced PTB by 2 days. We analysed pathogenic factors contributing to PTB and their effects on trophoblasts in vitro. TNF-α, IL-8, and COX-2 were upregulated in P.g.-infected placenta. Galectin-3 (Gal-3), an immune regulator, was significantly upregulated in placenta, amniotic fluid, and serum. In vitro, P.g.-lipopolysaccharide (P.g.-LPS) increased TNF-α and Gal-3 in trophoblasts via NF-κB/MAPK signalling. Gal-3 inhibition significantly downregulated P.g.-LPS-induced TNF-α production. TNF-α upregulated Gal-3. Gal-3 also increased cytokines and Gal-3 through NF-κB/MAPK signalling. Moreover, Gal-3 suppressed CD-66a expression at the maternal-foetal interface. Co-stimulation with Gal-3 and P.g.-LPS upregulated cytokine levels, while Gal-3 plus Aggregatibacter actinomycetemcomitans (A.a.)-or Escherichia coli (E. coli)-LPS treatment downregulated them, indicating the critical role of Gal-3 especially in P.g. dental infection-induced PTB. P.g.-dental infection induced PTB, which was associated with Gal-3-dependent cytokine production. New therapies and/or diagnostic systems targeting Gal-3 may reduce PTB.
production of prostaglandins, TNF-α, IL-6, and IL-8, which leads to more frequent and intense uterine contractions with consequential PTB 6, 7 .
Periodontal disease is a chronic infectious disease, mainly caused by gram-negative periodontal pathogens, which can enter the blood circulation and disseminate throughout the entire body. Periodontitis is considered a risk factor of systemic diseases such as cardiovascular disease and diabetes mellitus 8, 9 . In 1996, the results from a case-control study performed by Offenbacher et al. suggested that maternal periodontal disease was associated with a 7.9-fold increased risk for PTB/low birth weight 10 . In pregnant women with a diagnosis of threatened premature labour, periodontal pathogens were detected both in the periodontal pocket and in the amniotic fluid 11 . In addition, the presence of periodontal pathogens in the placenta was confirmed in cases of chorioamnionitis where PTB was also indicated 12 . However, the underlining mechanisms of periodontitis-induced PTB remain unclear.
Several experimental studies have revealed that Porphyromonas gingivalis (P.g.), a main periodontal pathogen, can invade the placental-fetal barrier to induce pregnancy complications in rodents and rabbit animal models [13] [14] [15] . However, the bacteria-delivery systems used, such as intravenous or peritoneal injection, the subcutaneous chamber model, and oral-gavage are quite different from the natural infection route used by P.g. to infect patients. Recently, we established a dental infection-induced PTB mouse model that showed long-term low-grade inflammation, which ideally imitates the clinical condition of pregnant women with periodontitis. In the model, P.g. dental infection induced PTB (by an average of 2 days). P.g. originating from a dental infection was detected in placental tissue by immunohistochemistry and PCR. Moreover, in P.g.-infected placenta, upregulation of inflammatory mediators such as TNF-α and COX-2 (inducible synthetase of prostaglandins) was observed, which can promote the initiation of labour 16 .
In the present study, our aim was to clarify PTB-related molecules that can differentiate PTB from term birth (TB), using our established animal model. We identified an interesting immune-regulatory molecule, Galectin-3 (Gal-3), which was upregulated in P.g.-infected placental tissue compared control placentas. Moreover, the underlining mechanisms, in which Gal-3 induces PTB, were studied a using human trophoblast cell line. 
Gal-3 Plays an Important Role in the Inflammatory Activity of P.g.-LPS. It is well known that
Gal-3 is one of important products from macrophages with LPS stimulation and is a key immunoregulator to produce inflammatory cytokines 17 .
P.g.-LPS upregulated Gal-3 secretion from trophoblasts (HTR-8 cells: a; p < 0.01) at day 3 ( Fig. 3A ) as well as macrophages (THP-1 cells: p < 0.01) at day 1, 2 (Supplement Fig. 1A ) and endothelial cells (Huh-1 cells: p < 0.01) at day 3 (Supplement Fig. 1B) . At 3 days after P.g.-LPS stimulation, TNF-α significantly secreted from HTR-8 cells (a; P < 0.01; Fig. 3B ). To examine the effect of TNF-α produced by P.g.-LPS stimulation on Gal-3 production, HTR-8 cells were incubated with rhTNF-α and Gal-3 secretion was examined in the culture medium. Significantly increased Gal-3 production was detected after 3 days rhTNF-α-stimulation (a; p < 0.01, Fig. 3A ).
To clarify the signaling pathways relating to Gal-3 production, inhibitors were used. CAPE (an NF-κB inhibitor) and U0126 (an ERK inhibitor) suppressed P.g.-LPS and rhTNF-α induced upregulation of Gal-3 secretion (c; p < 0.01, Fig. 3C ). Inhibition of NF-κB signalling significantly reduced constitutive secretion of Gal-3 in HTR-8 cells (c; p < 0.01, Fig. 3C ).
All examined NF-κB and MAPK signalling inhibitors completely downregulated P.g.-LPS induced TNF-α production (c; p < 0.01, Fig. 3D ). Moreover, the inflammatory activity of P.g.-LPS was restricted by treatment with a Gal-3 blocking antibody. P.g.-LPS-induced TNF-α secretion by HTR-8 cells was significantly reduced to control level after Gal-3 antibody treatment (**P < 0.01, Fig. 3E ). Gal-3, IL-8, and TNF-α gene-expression levels were down-regulated by Gal-3 blocking antibody but not COX-2 ( Fig. 3F ). (1 μg/ml) were measured. After 3 days, TNF-α production was significantly upregulated. (C,D) HTR-8 cells were pre-treated with or without CAPE (1 μg/ml) for 4 h, pre-exposed to dicumarol/SB203580/U0126 (10 μM) for 30 min, and then grown with or without P.g.-LPS (1 µg/ml) or rhTNF-α (10ng/ml) for 3 days. The Gal-3 or TNF-α concentration in the culture media was analysed by ELISA. CAPE, and U0126 inhibited Gal-3 production induced both by P.g.-LPS and rhTNF-α (C). All inhibitors used were significantly reduced TNF-α secretion from HTR-8 cells at 3 days after LPS-stimulation. Data are presented as the mean ± SD. a and b: significant difference (P < 0.01, p < 0.05) between untreated control, c: significant difference (P < 0.01) between P.g.-LPS/rhTNF-α stimulated and control group; 1-way ANOVA. (E,F) HTR-8 cells were treated with P.g.-LPS (1 μg/ml) with or without a Gal-3 blocking antibody (clone M3/38) or rat control IgG for 3 Days. Gal-3 antibody significantly reduced P.g.-LPS induced TNF-α production (E). COX-2, IL-8, and TNF-α mRNA-expression levels were examined. GAPDH expression was detected as an internal control (F). Data are presented as the mean ± SD. **P < 0.01; 1-way ANOVA. The experiments were performed at least 3 times with similar results. To clarify the signaling pathways relating Gal-3-induced TNF-α production, inhibitors were used. Inhibition of NF-κB, ERK and JNK signaling pathway significantly reduced Gal-3-induced TNF-α secretion ( Fig. 4C ).
Gal-3 Activated the JNK and NF-κB Pathways, Playing an Important Role in the Inflammatory

Gal-3 Inhibition Using a Blocking Antibody or Gene Knockdown Increased CD66a Expression.
CD66a is an adhesion molecule that is normally expressed in trophoblasts, functioning as an important adhesion mediator at the maternal-foetal interface 18 
Discussion
In this study, we used a mouse model of P.g.-dental infection. P.g., which is a main causative pathogen of chronic and periapical periodontitis, is infected from the pulp chamber because it requires anaerobic growth conditions 21 .
The pulp chamber provides ideal anaerobic conditions and is the natural infecting way of periapical periodontitis. Previously, we demonstrated that P.g. remained alive inside the pulp chamber, reproduced long enough to induce periapical periodontitis, and maintained upregulated LPS levels in the serum 22 . Moreover, we confirmed the establishment of chronic, low-grade systemic inflammation, including upregulated TNF-α, IL-17, IL-6, and IL-1β serum levels at 6-weeks post-P.g. infection, the time of mating 16 . These data indicated that the mouse model successfully mimicked the clinical conditions of pregnant women with chronic dental infection. We also reported previously that P.g.-infected mice showed PTB by 2 days, on average 16 , which was comparable with that observed by direct intrauterine injection of E. coli (10 4 CFU) 23 .
Interestingly, Gal-3, TNF-α and COX-2 immunoexpression dramatically increased in P.g.-infected placenta in this study. The Gal-3 level in the amniotic fluid and serum was also significantly upregulated in P.g.-infected mice (Fig. 2 ). Gal-3, a beta-galactoside-binding lectin, plays both pro-inflammatory and anti-inflammatory roles in the inflammation process 24 . Extracellular Gal-3 contributes to neutrophil adhesion, macrophage migration, and endocytosis, indicating the pro-inflammatory roles of Gal-3. Therefore, it is possible that extracellular Gal-3 may play an important role in the onset of PTB. However, to our knowledge, the relationship between Gal-3 and PTB has not yet been elucidated.
It is well accepted that bacterial LPS contributes to pathogenesis of PTB through TLR4 25 . LPS is a main virulence factor of P.g., and elevated LPS levels in the sera of P.g.-infected mice were observed in a previous study 22 . We reported that TNF-α, IL-8 and COX-2 expression, which relate to onset of PTB, were secreted from HTR-8 cells with P.g.-LPS stimulation 16 . Ren et al. also demonstrated that P.g.-LPS promoted IL-8 secretion from HTR-8 cells 26 .
P.g.-LPS stimulation increased Gal-3 expression in placental cells (trophoblasts) by activating the NF-κB and MAPK signaling pathways (Fig. 3A,C) . Moreover, exogenously applied rhGal-3 or rhTNF-α, which were produced by LPS-stimulated trophoblasts, also increased Gal-3 production. It was previously reported that extracellular Gal-3 modulated the production of cytokines such as IL-1β 27 , IL-5 28 , and IL-8 29 not only in immune cells, but also in another cell types 30 . In the present study, Gal-3 was also responsible for upregulating proinflammatory mediators, such as COX-2, IL-8, and TNF-α. Gal-3 and TNF-α, which were produced by P.g.-LPS stimulation in P.g.-infected placenta, induced additional Gal-3-production, finally leading to excessive cytokine expression. It was suggested that in placenta of P.g.-odontogenic infected animals, harmful cycle in cytokine through Gal-3 may be established. Moreover, inhibition of Gal-3 by Gal-3 neutralizing antibody significantly suppressed P.g.-LPS induced TNF-α production, resulting in reduction of IL-8 and COX-2. We consider that the regulation of Gal-3 in placenta may be a possible preventive strategy of PTB.
Our previous report showed that immunohistochemically P.g. detected in the placental cells (trophoblasts) of P.g.-dental infection mouse. In vitro study showed that HTR-8 cells with P.g.-infection increased secretion of COX-2, TNF-α, and IL-8 16 . Several reports indicated that infection of trophoblasts by P.g. induced cytokine expression 26, 31 and apoptosis 32, 33 through MAP kinase signalling 34 . It is indicating that P.g.-infection to trophoblasts also has impacts on pathogenesis of PTB caused by periodontitis.
In contrast, it was also reported that Gal-3 shows an anti-inflammatory effect by binding to LPS. Mey et al. 35 reported that Gal-3 binds to LPS from gram-negative bacteria, and Li et al. showed the inhibitory effect of Gal-3 20 . We examined the binding affinity between Gal-3 and various types of LPS. Here, we found that Gal-3 bound to LPS from E. coli and A.a., but not P.g.-LPS, in agreement with the report by Kato et al. 36 . LPS consists of a hydrophobic lipid embedded in the outer leaflet of the outer membrane, a core oligosaccharide (OS), and the O-polysaccharide side chain composed of several repeating units 37 . It was reported that heptose residues in core OS of LPS provided the attachment point with various types of LPS. Using heptose mutation, Quattroni et al. found that heptose in the core OS in Neisseria meningitidis was necessary for the Gal-3 binding to LPS 38 . The LPS core OS molecules of E. coli and A.a. contain heptose residues 39 , whereas P.g.-LPS lacks heptose residues 37, 40 . Co-stimulation of rhGal-3 and E. coli-LPS or A.a.-LPS significantly downregulated cytokine levels versus LPS treatment alone. However, since the anti-inflammatory effect of Gal-3 is limited in early stage of LPS stimulation, the prolonged and excessive production of Gal-3 finally may induce proinflammatory effect. On the other hand, co-stimulation with rhGal-3 and a low dose of P.g.-LPS revealed a synergistic effect on the upregulation of inflammatory mediators. Since P.g.-LPS can synergistically induce intense cytokine production in early stage of placental inflammation, in which abundant Gal-3 present, even P.g with low virulence LPS than E. coli, can be a risk for PTB.
Our investigation showed that Gal-3 inhibited CD66a expression. CD66a is an adhesion molecule of the carcinoembryonic antigen family. Bamberger et al. 18 reported that CD66a was strongly expressed by intermediate trophoblasts, endometrial epithelial cells, and endothelial cells at the maternal-fetal interface throughout pregnancy. Thus, CD66a may play an important role in adhesive trophoblast-endometrial and trophoblast-endothelial cell interactions. CD66a downregulation by Gal-3 may induce cell adhesion breakdown at the maternal-fetal interface and contribute to the initiation of placental abruption from the uterus.
Moreover, we clarified that Gal-3 levels in the amniotic fluid and maternal serum of P.g.-infected mice were significantly higher than those of NC mice, indicating that the Gal-3 level may be potent predictive biomarker for PTB. Predictive biomarkers for PTB are urgently needed to reduce PTB caused by maternal infection/inflammation during the gestation period. Several inflammatory biomarkers present in amniotic fluid have been proposed as predictors of intra-amniotic inflammation and preterm labour. IL-6 has shown the best sensitivity for predicting infection in patients with preterm labour 7, 41 . Recently, the combined use of IL-6 and proteomic biomarkers was recommended 42 . However, their clinical use is still limited. As mentioned above, we demonstrated significant Gal-3 elevation in the amniotic fluid of P.g. dentally infected mice. Gal-3 in the amniotic fluid may be an important predictive marker for PTB. However, examination of the amniotic fluid is invasive testing that causes an increased risk of abortion. Non-invasive diagnostic testing is key for screening pregnant individuals. Maternal serum is easily collected without threatening the pregnancy. In this study, we also detected Gal-3 upregulation in the maternal serum. This is the first investigation of the association of serum Gal-3 upregulation with PTB. In human serum, Gal-3 is constitutively detected with mean serum levels of approximately 5 ng/ml in healthy adults 43 . Increase serum Gal-3 is associated with various pathological conditions, such as immune responses 44 and malignancy 24 . Demmert et al. 45 demonstrated that the Gal-3 level was significantly higher in cord blood of small-for-gestational-age infants. However, there is still no report showing a relationship between maternal serum Gal-3 levels and PTB. In the present study, we detected significant upregulation of the serum Gal-3 level at 15gd in P.g. dentally infected mice with PTB. Serum Gal-3 may serve as a novel predictive biomarker for PTB, although further clinical studies are needed to clarify the usefulness of Gal-3 upregulation in the amniotic fluid and/or serum as a predictive marker of PTB.
Based on our results, we considered possible mechanisms responsible for P.g. dental infection-induced PTB through Gal-3 ( Fig. 7) . Dental P.g. infection increases inflammatory cytokines in the serum and induces P.g.-LPS translocation in the placenta through the blood circulation. In the placenta, P.g.-LPS upregulated inflammatory mediators such as TNF-α, IL-8, and COX-2 directly or indirectly through Gal-3 production. Upregulated TNF-α can also induce Gal-3 production, which may help establish the excessive production of pro-inflammatory mediators through Gal-3. Gal-3 inhibits CD66a expression, which results in the breakdown of cell adhesion and induces placental abruption. In addition, the regulation of inflammatory mediators induces cervical ripening and activation of the myometrium. Taken together, the findings indicate that Gal-3 plays an important role in PTB induced by dental infection with P.g. Thus, dental treatments to prevent and/or eliminate P.g. infection should be meticulously performed throughout the world to reduce the PTB rate. Gal-3 should be considered as one of the PTB biomarkers in the amniotic fluid and/or serum, and should be considered as a possible new target for preventing PTB.
Materials and Methods
Animal Model. This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the Hiroshima University Animal Research Committee and AVMA Guidelines on Euthanasia. The protocol ( Supplementary Fig. 3 ) described below was approved by the Committee on the Ethics of Animal Experiments of the Hiroshima University (Permit Number: A09-89). Eight-week-old female C57Bl/6J mice (Charles River Japan, Inc., Yokohama, Japan) were housed in a specific-pathogen free facility in 12-h light-dark cycles with access to water and food ad libitum, and health monitoring was conducted every day. Mice were randomly divided into 2 groups with or without P.g. infection and designated as the P.g.-infected group or the non-infected control (NC) group, respectively. P.g. dental infection was performed as described previously 16, 21 . Briefly, the pulp chambers of the upper first molars on both sides were opened with a #1/2 round burr. After removing the coronal pulp, a small cotton swab containing 10 8 colony-forming units (CFU) of P.g. (W83 strain) was inserted into the pulp chamber and sealed with Caviton (GC Co., Tokyo, Japan). At 6 weeks post-P.g. infection, mating was started. Placental tissues, amniotic fluid, and serum were harvested at 15 gestational day (gd).
Histology. Placental tissues were fixed in 10% neutral buffered formalin for 24 h. Samples were processed, embedded in paraffin, and serial sections of 4.5 μm in thickness were obtained for hematoxylin and eosin (HE) staining and immunohistochemistry, which was performed as described previously 16 . Staining was visualized using the DAB Peroxidase (HRP) Substrate Kit (Dako Japan, Tokyo, Japan) to produce a brown reaction product. Immunohistochemistry were performed using high polymer method (Histofine Max-PO; Nichirei Biosciences). A primary Gal-3 antibody (BioLegend, Inc., San Diego, CA, USA; 1: 500) was used. Specificity was ascertained by substituting PBS/serum for the antibody.
Cell Lines and Cell Culture. HTR-8/Svneo cells (human trophoblast cell line) were kindly provided by
Professor Charles H. Graham (Queen's University, Canada). The cells were grown in RPMI 1640 media (Nissui Pharmaceutical Co., Tokyo, Japan) supplemented with 10% heat-inactivated foetal bovine serum (Invitrogen) and 100 U/ml penicillin-streptomycin (Gibco, Tokyo, Japan). For the experiments, cells were seeded at a density of 5 × 10 5 cells in 35-mm culture dishes. The cells were maintained at 37 °C in a normal atmosphere containing 5% CO 2 . 
Enzyme-Linked Immunosorbent Assay (ELISA). Mouse
RNA Isolation from Placental Tissues/Cells and RT-PCR Analysis.
Total RNA was extracted using the RNeasy Mini Kit (Qiagen, K.K., Tokyo, Japan) following the manufacturer's instructions. The RNA concentration and purity were determined using standard spectrophotometric methods. One microgram of total RNA was used for cDNA synthesis using the ReverTra Dash Kit (TOYOBO, Osaka, Japan). Total cDNA was amplified using the Go Taq Green Master Mix (Promega, Madison, WI, USA). Amplification of human or mouse COX-2, Gal-3, IL-8/mKC, and TNF-α was performed in a MyCycler TM thermal cycler (Bio-Rad, Tokyo, Japan) for 30 cycles of denaturation for 30 s at 94 °C, annealing for 30 s at 58 °C, and extension for 1 min at 72 °C, using primers for all each target mentioned above. GAPDH expression was detected as an internal control. PCR primer sequences are listed in Supplemental Table 1 . The amplification products were resolved on 1.5% agarose/TAE gels (Nacalai Tesque, Inc., Kyoto, Japan), electrophoresed at 100 mV, and visualized by ethidium-bromide staining.
Quantitative 
Small interfering RNA (siRNA)-mediated Gal-3 Gene Knockdown. siRNAs against human
Gal-3 were purchased from Bonac Corporation (Fukuoka, Japan). The siRNA sequences are shown in Table 1 . Transfection was performed using Lipofectamine RNAi Max (Invitrogen), according to the manufacturer's recommended protocol.
Western Blotting. Western blotting was performed as previously described 46 . Briefly, HTR-8 cell pellets (5 × 10 5 cells) were resuspended in ice-cold lysis buffer. Proteins were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and electro-blotted onto a nitrocellulose membrane. After blocking the membrane in 3% milk for 30 min, immunoblotting was performed using primary antibodies (anti-phospho-JNK, anti-phospho-c-Jun, anti-phospho-ERK1/2, anti-ERK1/2, anti-phospho-NF-κB p65, anti-RelB [Cell Signaling Technology], or anti-CD66a [Epitomics, Burlingame, CA, USA]) and secondary antibodies (GE Healthcare Life Science, Tokyo, Japan), as indicated. β-actin (Sigma-Aldrich, St. Louis, MO, USA) was detected as an internal control. The results were visualized using the ECL Western Blotting Detection System (GE Healthcare, UK).
Statistical Analysis. Data are presented as the mean ± standard deviation. Statistical differences among experimental groups were evaluated by 1-way analysis of variance (ANOVA), followed by Tukey's post-hoc test or Student's t-test using GraphPad Prism (version 6.0c, CA, USA) with the levels of significance set at * P < 0.05 and ** P < 0.01. Table 1 . Sequences of primer pairs.
